BioSpace News Archive

Business

Abattis Bioceuticals Signs National Distribution Agreement With Shefield & Sons

Abattis Bioceuticals Corp is pleased to announce that the Company has signed a Distribution Agreement with Shefield & Sons Tobacconists Inc. (“Shefield & Sons”) to sell the Abattis vaporizer line in all Shefield & Sons stores across Canada.

November 27, 2018
·
6 min read
Policy

Statement from FDA Commissioner Scott Gottlieb, M.D., on how modern predicates can promote innovation and advance safety and effectiveness of medical devices that use 510(k) pathway

Earlier this week, the FDA announced new steps to modernize FDA’s 510(k) clearance pathway, used for low- to moderate-risk devices that are substantially equivalent to a device already on the market, known as a predicate device.

November 27, 2018
·
4 min read
Business

AGM Trading Update

Allergy Therapeutics plc (AIM: AGY), the fully integrated commercial biotechnology company specialising in allergy vaccines, today provides an AGM trading and regulatory update ahead of its Half Year Results to be announced in March 2019.

November 27, 2018
·
2 min read
Job Trends

The Center for Cell and Gene Therapy at Baylor College of Medicine to Present at the 60th American Society of Hematology Annual Meeting

Marker Therapeutics, Inc. (NASDAQ:MRKR), a clinical-stage immuno-oncology company, today reported that data from three abstracts—including an oral presentation—were accepted for presentation at the 60th American Society of Hematology Annual Meeting (ASH 2018)

November 27, 2018
·
4 min read
Sierra Oncology to Host Analyst Call Highlighting Clinical Data on Momelotinib’s Anemia Benefit

Sierra Oncology, Inc. (Nasdaq: SRRA), a clinical stage drug development company focused on advancing targeted therapeutics for the treatment of patients with significant unmet needs in hematology and oncology, today announced that it will host an Analyst & Investor call on Monday, December 3rd

November 27, 2018
·
4 min read
Business

Vivos Therapeutics, Inc. Announces New Chief Financial Officer

Vivos Therapeutics, a company focused on addressing the root causes of mild-to-moderate sleep apnea, announced Brad Amman has joined the company as Chief Financial Officer.

November 27, 2018
·
2 min read
Deals

ACADIA Pharmaceuticals Prices Public Offering of 16,176,471 Shares of Its Common Stock

ACADIA Pharmaceuticals Inc. today announced the pricing of an underwritten public offering of 16,176,471 shares of its common stock, offered at a price to the public of $17.00 per share.

November 27, 2018
·
4 min read
Drug Development

Stoke Therapeutics to Present New Data on Lead Program at American Epilepsy Society’s 2018 Annual Meeting

Stoke Therapeuticss and research collaborators from the University of Michigan will present new preclinical data supporting Stoke’s development of its antisense oligonucleotide technology to treat Dravet Syndrome at the annual meeting of the American Epilepsy Society in New Orleans.

November 27, 2018
·
1 min read
Business

BioClin Therapeutics Announces Name Change to Rainier Therapeutics

The new name will be implemented immediately

November 27, 2018
·
2 min read
Bindex Measurement Revolutionizes Osteoporosis Diagnostics in US - One Million Patients Have Been Measured in Just 18 Months

Bone Index Ltd. announces that one million patients have been measured with Bindex® in the U.S. in 2018.

November 27, 2018
·
2 min read